FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jul. 31, 2012--
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Loudoun
Anesthesia Associates, a physician group practice that provides
anesthesia services at Inova Loudoun Hospital and Inova Loudoun
Ambulatory Surgery Center in Leesburg, Va.
American Anesthesiology has an established relationship with the Inova
Health system as part of their first anesthesia acquisition of Fairfax
Anesthesiology Associates, Inc. in 2007.
Loudoun Anesthesia Associates was founded in 1994 and consists of 12
anesthesiologists and 17 anesthetists, providing anesthesia services
across a wide spectrum of subspecialty areas.
"Joining American Anesthesiology will provide us with the resources we
need, from research, education and technology to infrastructure and
administrative support, to ensure the future success of our practice,"
said Lorna Miller, M.D. who will serve as medical director for
the American Anesthesiology practice. "We also look forward to
collaborating with leading anesthesiologists across the country to help
improve overall patient outcomes. This partnership will enable us to
continue providing the highest level of care to our patients in this
community.”
The physicians joining as a result of this transaction will now be part
of MEDNAX’s American Anesthesiology division, which consists of more
than 1,200 anesthesia providers, including more than 485 physicians and
750 anesthetists practicing in North Carolina, Florida, Georgia, New
Jersey, Tennessee, Texas and Virginia, with administrative offices in
Sunrise, Fla. and Raleigh, N.C.
This practice was acquired for cash and the transaction is expected to
be immediately accretive to earnings. No additional terms of the
transactions were disclosed.
With this acquisition, nine physician group practices have become part
of MEDNAX in 2012, five as part of American Anesthesiology and four as
part of Pediatrix Medical Group.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 300 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
services. Today, American Anesthesiology includes more than 1,200
anesthesiologists and advanced practitioners who provide anesthesia care
to patients in connection with surgical and other procedures as well as
pain management. MEDNAX, through its affiliated professional
corporations, employs more than 1,900 physicians in 34 states and Puerto
Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
Source: MEDNAX, Inc.
MEDNAX, Inc.
David T. Parker, 954-384-0175, x 5300
Vice
President, Investor Relations & Corporate Communications
david_parker@mednax.com